Ventilation Center
Center Home
How it Works
Who Can be Helped?
Inspiratory Aids
Expiratory Aids
Techniques for Children
Intensive Care Protocol
Outpatient Protocol
Selected Studies
Neuromuscular Disease
Spinal Muscular Atrophy
About the Center
Meet the Staff
Directions
Contact Us
Ventilation CenterHow it WorksExpiratory Aids Printer Friendly Page
Inspiratory and expiratory muscle aids are devices and techniques that involve the manual or mechanical application of forces to the body or intermittent pressure changes to the airway to assist inspiratory or expiratory muscle function. The most important inspiratory aid is to receive air under pressure when one inhales (intermittent positive pressure ventilation or IPPV). The most important expiratory aid is to have a negative pressure (vacuum) applied to the airway via the nose and mouth when one coughs along with a manual thrust to the belly to further increase cough flows.

No one should receive supplemental oxygen, bronchodilators, or other medications as an alternative to normalizing blood oxygen levels by normalizing lung ventilation. Using oxygen rather than assisted ventilation results in worsening of carbon dioxide retention and inevitably results in respiratory failure.

Manually Assisted Coughing

Illness and death in people with generalized weakness is almost always due to respiratory difficulty that occurs because of a weak cough. Breathing (inspiratory), expiratory, and throat (bulbar) muscles are needed for effective coughing. The latter are predominantly the abdominal muscles. Clearing airway secretions can be a continual problem but it most often occurs during chest infections and following general anesthesia for surgery for any reason.

Peak cough flows (PCF) most often exceed 160 liters per minute to be effective for coughing up airway debris. PCF are increased by manually assisted coughing. If the vital capacity is less than 1.5 liters, insufflating or air stacking to the maximum insufflation capacity (MIC) becomes crucial to optimize cough flows. Once the person is insufflated to the MIC, an abdominal thrust is timed to the cough to increase the flow. Techniques of manually assisted coughing involve different hand and arm placements for thrusts. A belly thrust with one hand while applying counterpressure to the chest with the other arm and hand further increases assisted PCF for 20% of people.

Manually assisted coughing requires a cooperative patient, good coordination between the patient and caregiver, and adequate physical effort and often frequent application by the caregiver. It is usually ineffective in the presence of significant back deformity. Abdominal compressions should not be used for one and one-half hours following a meal, however, chest compressions can be used to augment PCF. The inability to generate over 160 liters per minute of assisted PCF despite having a vital capacity or MIC greater than 1 liter usually indicates fixed upper airway obstruction or severe throat muscle weakness and airway collapse during coughing attempts. Vocal cord adhesions or paralysis may have resulted from a previous translaryngeal intubation or tracheostomy. Some lesions, especially the presence of obstructing granulation tissue, can be corrected surgically. When inadequate, the most effective alternative for generating optimal PCF and clearing airway secretions is the use of MI-E.

Mechanical Insufflation-Exsufflation (MI-E)

Mechanical Cough Assist devices (J. H. Emerson Co., Cambridge, MA) deliver deep insufflations followed immediately by deep exsufflations. The insufflation and exsufflation pressures and delivery times are independently adjustable. Except after a meal, an abdominal thrust is applied in conjunction with the exsufflation. MI-E can be provided via an oral-nasal interface, a simple mouthpiece, or via an invasive airway tube like a tracheostomy tube. When delivered via the latter, the cuff, when present, should be inflated.

The Cough-Assist can be manually or automatically cycled. Manual cycling facilitates caregiver-user coordination of inspiration and expiration with insufflation and exsufflation, but it requires hands to deliver an abdominal thrust, to hold the mask on the patient, and to cycle the machine. One treatment consists of about five cycles of MI-E followed by a short period of normal breathing or ventilator use to avoid hyperventilation. Insufflation and exsufflation pressures are almost always from +35 to +60 cm H2O to -35 to -60 cm H2O. Most patients use 35 to 45 cm H2O pressures insufflations and exsufflations. In experimental models, +40 to -40 cm H2O pressures have been shown to provide maximum forced deflation volumes and flows (see (3)further information). Multiple treatments are given in one sitting until no further secretions are expulsed and any secretion or mucus induced oxygen desaturations are reversed. Use can be required as frequently as every few minutes around the clock during chest colds. Although no medications are usually required for effective MI-E in people with weak muscles, liquefaction of sputum using heated aerosol treatments may facilitate exsufflation when secretions are inspissated.

Whether used via the nose or mouth or via invasive indwelling airway tubes, routine airway suctioning misses the left lung about 90% of the time so that 80% of pneumonias are in the left lung. MI-E via an airway tube provides the same exsufflation flows in both left and right airways without the discomfort or airway trauma of tracheal suctioning and it can be effective when suctioning isn't. Patients invariably prefer MI-E to suctioning for comfort and effectiveness and they find it less tiring. Deep suctioning, whether via airway tube or via the upper airway, can essentially be discontinued for most patients.

The use of MI-E has permitted us to consistently extubate people with neuromuscular disease following general anesthesia despite their lack of any ability to breathe on their own, and to manage them with noninvasive IPPV. It has also permitted us to avoid intubation or to quickly extubate people in acute ventilatory failure and with profuse airway secretions due to intercurrent chest infections. MI-E in a protocol with manually assisted coughing, oximetry feedback, and home use of noninvasive IPPV was shown to effectively decrease hospitalizations and respiratory complications and mortality for people with neuromuscular diseases. It may not be effective if the user can not cooperate sufficiently to keep the airway open, if there is a fixed upper airway obstruction, or if upper airway dilator muscles can not maintain sufficient patency to allow for PCF to exceed 160 L/m. This is most often seen in advanced amyotrophic lateral sclerosis with severe throat muscle weakness. MI-E has been demonstrated to be extremely safe even when used many times at pressures of 40 to 60 cm H2O. It is rarely effective for people of any age at pressures less than 35 cm H2O.

Return to Top Printer Friendly Page